The Sickle Cell Anemia Team is developing a low-cost diagnostic tool for use in screening individuals in low-middle income countries, enabling early intervention and reducing mortality. Xuanhong Cheng ’s team ( Ashleigh Crawford ’20, Maria Lancia ’21, Olivia O'Donnell ’20) got the VentureWell E-team phase I grant in summer 2019.